Quantcast

Cornhusker State News

Saturday, May 18, 2024

FDA conducted third highest number of inspections on Biologics companies in Nebraska during 2023

Webp qjor7q6aba3j2gn1lh89sh3yxtfn

DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA | Official Website

DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA | Official Website

In 2023, eight Biologics companies received eight FDA inspections in Nebraska, according to the U.S. Food and Drug Administration (FDA).

This was the third highest number of inspections per type of company made by the FDA in Nebraska, equalling 6.4% of all inspections in 2023.

Of all the Nebraska companies involved in the Biologics sector, Regional West Medical Center received the most citations from the FDA in 2023.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

Top 10 FDA Inspections by Number of Actions Indicated in Nebraska During 2023
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Bioresearch Monitoring3----
Blood and Blood Products31--
Compliance: Devices43--
Drug Quality Assurance11--
Food Composition, Standards, Labeling and Econ4----
Foodborne Biological Hazards4411
Monitoring of Marketed Animal Drugs, Feed, and Devices4833
Postmarket Assurance: Devices7----
Technical Assistance: Food and Cosmetics7----
Vaccines and Allergenic Products3----

MORE NEWS